Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis
Open Access
- 1 December 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 515 (1-2) , 575-582
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- In situ forming collagen–hyaluronic acid membrane structures: Mechanism of self-assembly and applications in regenerative medicineActa Biomaterialia, 2013
- Suppository formulations as a potential treatment for nephropathic cystinosisJournal of Pharmaceutical Sciences, 2012
- Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea modelsInternational Journal of Pharmaceutics, 2012
- Gel formulations for treatment of the ophthalmic complications in cystinosisInternational Journal of Pharmaceutics, 2010
- Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosisEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- A potential new prodrug for the treatment of cystinosis: Design, synthesis and in-vitro evaluationBioorganic & Medicinal Chemistry Letters, 2008
- Carrageenan–gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Corneal Crystals in Nephropathic Cystinosis: Natural History and Treatment with Cysteamine EyedropsMolecular Genetics and Metabolism, 2000
- Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorptionInternational Journal of Pharmaceutics, 1987
- Removal of Corneal Crystals by Topical Cysteamine in Nephropathic CystinosisNew England Journal of Medicine, 1987